3K3A-APC
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for 3K3A-APC, covering 2014-04-10 to 2024-10-01. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Evaluation of 3K3A-APC in Ischemic Stroke [Phase 3]